JP2021526547A5 - - Google Patents

Info

Publication number
JP2021526547A5
JP2021526547A5 JP2021510540A JP2021510540A JP2021526547A5 JP 2021526547 A5 JP2021526547 A5 JP 2021526547A5 JP 2021510540 A JP2021510540 A JP 2021510540A JP 2021510540 A JP2021510540 A JP 2021510540A JP 2021526547 A5 JP2021526547 A5 JP 2021526547A5
Authority
JP
Japan
Prior art keywords
complex carbohydrate
vaccine composition
protein antigen
sequence
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021510540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526547A (ja
JP7511188B2 (ja
Filing date
Publication date
Priority claimed from GBGB1807303.1A external-priority patent/GB201807303D0/en
Application filed filed Critical
Publication of JP2021526547A publication Critical patent/JP2021526547A/ja
Publication of JP2021526547A5 publication Critical patent/JP2021526547A5/ja
Priority to JP2024002863A priority Critical patent/JP7833736B2/ja
Application granted granted Critical
Publication of JP7511188B2 publication Critical patent/JP7511188B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510540A 2018-05-03 2019-05-02 複合糖質ワクチン Active JP7511188B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024002863A JP7833736B2 (ja) 2018-05-03 2024-01-11 複合糖質ワクチン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1807303.1 2018-05-03
GBGB1807303.1A GB201807303D0 (en) 2018-05-03 2018-05-03 Glyconjugate vaccines
PCT/EP2019/061266 WO2019211386A1 (en) 2018-05-03 2019-05-02 Glyconjugate vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024002863A Division JP7833736B2 (ja) 2018-05-03 2024-01-11 複合糖質ワクチン

Publications (3)

Publication Number Publication Date
JP2021526547A JP2021526547A (ja) 2021-10-07
JP2021526547A5 true JP2021526547A5 (cg-RX-API-DMAC7.html) 2022-04-26
JP7511188B2 JP7511188B2 (ja) 2024-07-05

Family

ID=62598278

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021510540A Active JP7511188B2 (ja) 2018-05-03 2019-05-02 複合糖質ワクチン
JP2024002863A Active JP7833736B2 (ja) 2018-05-03 2024-01-11 複合糖質ワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024002863A Active JP7833736B2 (ja) 2018-05-03 2024-01-11 複合糖質ワクチン

Country Status (6)

Country Link
US (2) US12048743B2 (cg-RX-API-DMAC7.html)
EP (1) EP3787675A1 (cg-RX-API-DMAC7.html)
JP (2) JP7511188B2 (cg-RX-API-DMAC7.html)
CN (2) CN112384240B (cg-RX-API-DMAC7.html)
GB (1) GB201807303D0 (cg-RX-API-DMAC7.html)
WO (1) WO2019211386A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4748391A1 (en) * 2024-11-20 2026-05-27 MinervaX ApS N-terminal region of a group b streptococcus surface protein as a carrier for the capsular polysaccharide

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
NZ230747A (en) 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
WO1990014837A1 (en) 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
SE0202110D0 (sv) 2002-07-05 2002-07-05 Isconova Ab Iscom preparation and use thereof
SE0301998D0 (sv) 2003-07-07 2003-07-07 Isconova Ab Quil A fraction with low toxicity and use thereof
GB0421083D0 (en) * 2004-09-22 2004-10-27 Glaxosmithkline Biolog Sa Purification process
SI2257307T1 (sl) 2008-02-20 2018-09-28 Glaxosmithkline Biologicals S.A. Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic
US20120135037A1 (en) 2009-06-01 2012-05-31 Mizel Steven B Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
CN103533954B (zh) 2011-03-02 2015-09-09 诺华股份有限公司 含较低剂量的抗原和/或佐剂的联合疫苗
US9040057B2 (en) 2011-09-25 2015-05-26 Chang Gung Medical Foundation, Linkou Branch Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases
WO2013131983A1 (en) * 2012-03-07 2013-09-12 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
GB201301085D0 (en) 2013-01-22 2013-03-06 London School Hygiene & Tropical Medicine Glycoconjugate Vaccine
EP4272750A3 (en) * 2013-02-07 2024-01-24 Children's Medical Center, Corp. Protein antigens that provide protection against pneumococcal colonization and/or disease
GB201610599D0 (en) * 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition

Similar Documents

Publication Publication Date Title
AU2019338473B2 (en) Multivalent pneumococcal vaccines
Wizemann et al. Adhesins as targets for vaccine development
JP4848552B2 (ja) 変異型ニューモリシンタンパク質
RU2221045C2 (ru) ОМР26 АНТИГЕН Haemophilus influenzae, КОДИРУЮЩАЯ ЕГО НК И ЕГО ИСПОЛЬЗОВАНИЕ
EP2241625A1 (en) Proteinase K resistant surface protein of neisseria meningitidis
JP2022514704A5 (cg-RX-API-DMAC7.html)
RU2757426C2 (ru) Иммунногенный слитый белок
JP2006506989A5 (cg-RX-API-DMAC7.html)
JP2010011868A5 (cg-RX-API-DMAC7.html)
NZ560966A (en) Nucleic acids and proteins from streptococcus groups A & B
JP2006512402A5 (cg-RX-API-DMAC7.html)
AU2019404924B2 (en) O-linked glycosylation recognition motifs
JP2010508276A5 (cg-RX-API-DMAC7.html)
JP2023531059A (ja) 肺炎桿菌o抗原ワクチン
JP2021528059A5 (cg-RX-API-DMAC7.html)
CN105111288A (zh) 鲍曼不动杆菌亚单位疫苗抗原蛋白与应用
Khan et al. Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice
CN116063548A (zh) 一种融合蛋白KP-Ag1及其用作肺炎克雷伯菌疫苗抗原的应用
CN105497884B (zh) 外膜蛋白Omp22作为鲍曼不动杆菌疫苗靶点的应用
KR20120010906A (ko) pep27 유전자 돌연변이를 포함하는 약독화된 폐렴구균 균주 및 이의 용도
CN113631186B (zh) 肺炎球菌表面蛋白
CN107050442A (zh) 用于预防β‑溶血链球菌(BHS)疾病的多组分免疫原性组合物
WO2022101745A3 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN103141739A (zh) 一种基于复合糖修饰作用的低致敏乳蛋白粉及制备方法
JP2024540479A5 (cg-RX-API-DMAC7.html)